306 results on '"Campbell, Norm R.C."'
Search Results
2. 2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas
3. Laboratory reporting of framingham risk score increases statin prescriptions in at-risk patients
4. WHO HEARTS: A Global Program to Reduce Cardiovascular Disease Burden: Experience Implementing in the Americas and Opportunities in Canada
5. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
6. Is there a safe level for adding sodium to food versus is it safe to reduce dietary sodium intake?
7. Reduction de l'apport alimentaire en sodium au Canada: d'autres mesures s'imposent pour atteindre les cibles mondiales 2025
8. Nonvalidated Home Blood Pressure Devices Dominate the Online Marketplace in Australia: Major Implications for Cardiovascular Risk Management
9. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
10. The pharmacist’s role in facilitating the accurate measurement of home blood pressure
11. Global Marketing and Sale of Accurate Cuff Blood Pressure Measurement Devices
12. Lancet commission on hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure
13. Epidemiology of Hypertension in Canada: An Update
14. Optimizing observer performance of clinic blood pressure measurement: a position statement from the Lancet Commission on Hypertension Group
15. Formulas to Estimate Dietary Sodium Intake From Spot Urine Alter Sodium-Mortality Relationship
16. The estimated impact of changes in population hypertension control on cardiovascular disease in Canada between 2000 and 2017.
17. Declaracion de posicion del Grupo de la Comision Lancet de Hipertension con respecto a la mejora mundial de las normas de exactitud para los dispositivos de medicion de la presion arterial
18. The Urgent Need to Re-establish a Health Coalition Focused on Hypertension Prevention and Control in Canada
19. Relationship Between Primary Care Physician Visits and Hospital/Emergency Use for Uncomplicated Hypertension, an Ambulatory Care-Sensitive Condition
20. HEARTS en las Américas: innovaciones para mejorar el manejo de la hipertensión y del riesgo cardiovascular en la atención primaria
21. Primary Care Physician Visits by Patients With Incident Hypertension
22. Ethnicity and Health Literacy : A Survey on Hypertension Knowledge among Canadian Ethnic Populations
23. Dietary sodium reduction in Canada: more action is needed to reach the 2025 global targets
24. HEARTS in the Americas: innovations for improving hypertension and cardiovascular disease risk management in primary care
25. Hospitalization for Uncomplicated Hypertension: An Ambulatory Care Sensitive Condition
26. Outcomes Among 3.5 Million Newly Diagnosed Hypertensive Canadians
27. Monitoring and Evaluating Efforts to Control Hypertension in Canada: Why, How, and What It Tells Us Needs to Be Done About Current Care Gaps
28. Antihypertensive Medication Use, Adherence, Stops, and Starts in Canadians With Hypertension
29. Factors Associated With Lack of Awareness and Uncontrolled High Blood Pressure Among Canadian Adults With Hypertension
30. Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas
31. Diretrizes de 2021 da Organização Mundial da Saúde sobre o tratamento medicamentoso da hipertensão arterial: repercussões para as políticas na Região das Américas
32. HEARTS en las Américas: un ejemplo mundial del uso de dispositivos automatizados de medición de la presión arterial validados clínicamente en la prevención y el manejo de las enfermedades cardiovasculares en entornos de atención primaria de salud
33. Statin Use in Canadians: Trends, Determinants and Persistence
34. 24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk
35. Hypertension Surveillance in Canada: Minimum Standards for Assessing Blood Pressure in Surveys
36. Regional variations in not treating diagnosed hypertension in Canada
37. Hypertension: Are you and your patients up to date?
38. Les recommandations à l'égard de l'hypertension artérielle sont-elles pertinentes pour la santé publique ?
39. Hypertension Recommendations: Are They Relevant to Public Health?
40. Dietary sodium and cardiovascular disease in China: concerns about the methods, conclusions, and evidence review
41. Revision sistematica de estudios comparativos entre recoleccion de muestras de orina de 24 horas y puntual para calcular el consumo de sal en la poblacion
42. Reduccion del consumo de sal para prevenir la hipertension y las enfermedades cardiovasculares
43. Necesidad de programas coordinados para mejorar la salud a escala mundial mediante la optimización de la ingesta de sal y yodo
44. Actitudes, conocimientos y comportamiento de los consumidores en relación con el consumo de sal en países centinelas de la Región de las Americas
45. Iniciativas para reducir la sal alimentaria en la Región de las Américas
46. Reducing dietary sodium and decreases in cardiovascular disease in Canada
47. Changes in lifestyle after hypertension diagnosis in Canada
48. Spot Urine Formulas to Estimate 24-Hour Urinary Sodium Excretion Alter the Dietary Sodium and Blood Pressure Relationship
49. Within-visit and between-visit intra-individual blood pressure variability in an unselected adult population from rural China
50. Re-calculation of sodium risks needs better reconciliation with consumption levels and risk parameters.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.